Buchumschlag

Features of hepcidin expression in patients with breast cancer

Gespeichert in:

Bibliographische Detailangaben
Datum:	2015
Hauptverfasser:	Yu. Lukianova, T. M. Yalovenko, V. F. Chekhun
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	2015
Schriftenreihe:	Oncology
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0000465451
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
von: S. M. Hrybach, et al.
Veröffentlicht: (2018)

Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
von: L. A. Nalieskina, et al.
Veröffentlicht: (2018)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
von: Naleskina, L.A., et al.
Veröffentlicht: (2016)

The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
von: V. F. Chekhun, et al.
Veröffentlicht: (2017)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: O. V. Shepil, et al.
Veröffentlicht: (2014)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: Shepil, O.V., et al.
Veröffentlicht: (2014)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
von: V. F. Chekhun, et al.
Veröffentlicht: (2016)

Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
von: Chekhun, V.F., et al.
Veröffentlicht: (2009)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2016)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: S. Chekhun, et al.
Veröffentlicht: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
von: L. M. Kovalevska, et al.
Veröffentlicht: (2019)

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
von: Lyalkin, S.A., et al.
Veröffentlicht: (2023)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
von: L. A. Nalieskina, et al.
Veröffentlicht: (2017)

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
von: Timovska, Yu., et al.
Veröffentlicht: (2011)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Surgery features in the treatment of patients with HER2-neu positive breast cancer
von: I. Y. Halaichuk
Veröffentlicht: (2020)

The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
von: Yu. Lukianova, et al.
Veröffentlicht: (2017)

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: S. V. Chekhun, et al.
Veröffentlicht: (2015)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: S. V. Chekhun, et al.
Veröffentlicht: (2014)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: Chekhun, S.V., et al.
Veröffentlicht: (2014)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

Chromosomal Radiosensitivity in Ukrainian breast cancer patients and healthy Individuals
von: Ryabchenko, N.M., et al.
Veröffentlicht: (2012)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: V. F. Chekhun, et al.
Veröffentlicht: (2015)

Heterogeneity of premetastatic niches gene expression in breast cancer cells
von: L. A. Tashireva, et al.
Veröffentlicht: (2015)

Heterogeneity of premetastatic niches gene expression in breast cancer cells
von: Tashireva, L.A., et al.
Veröffentlicht: (2015)

The ways to optimize the treatment of patients with regional breast cancer
von: V. H. Dubinina, et al.
Veröffentlicht: (2017)

Study of trace elements status of breast cancer patients
von: M. N. Tillashaykhov, et al.
Veröffentlicht: (2017)

Study of trace elements status of breast cancer patients
von: Tillashaykhov, M.N, et al.
Veröffentlicht: (2017)

Superroxide radicals: initiation of metastases in patients with breast cancer
von: A. P. Burlaka, et al.
Veröffentlicht: (2017)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
von: Todor, I.N., et al.
Veröffentlicht: (2012)

Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: Chekhun, S.V., et al.
Veröffentlicht: (2015)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Modern algorithm of treatment of patients with breast cancer and metastases in bone
von: O. V. Ponomareva, et al.
Veröffentlicht: (2015)

The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
von: Ürün, Y., et al.
Veröffentlicht: (2015)